Global venture capital firm with a focus on early and growth-stage technology companies.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| Solar Materials | 2023 | Grant | Undisclosed | Magdeburg |
| QuantPi | 2023 | Grant | Undisclosed | Saarbrücken |
| NIMBLE Diagnostics | 2023 | Grant | Undisclosed | Barcelona |
| Newrotex Ltd | 2023 | Grant | $25K | Oxford |
| Thirona | 2023 | Series B | $5.4M | Nijmegen |
| X-trodes | 2023 | Seed | $3.0M | Herzliya |
| BioSimulytics | 2023 | Grant | Undisclosed | Dublin |
| Hooke Bio | 2023 | Grant | $2.7M | Limerick |
| Cephalgo | 2023 | Grant | $2.7M | Strasbourg |
| Molecular Attraction | 2023 | Grant | Undisclosed | Stockholm |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 326 | Solar Materials | Grant | Undisclosed | Magdeburg, Germany |
| 327 | QuantPi | Grant | Undisclosed | Saarbrücken, Germany |
| 328 | NIMBLE Diagnostics | Grant | Undisclosed | Barcelona, Spain |
| 329 | Newrotex Ltd | Grant | $25K | Oxford, United Kingdom |
| 330 | Thirona | Series B | $5.4M | Nijmegen, The Netherlands |
| 331 | X-trodes | Seed | $3.0M | Herzliya, Israel |
| 332 | BioSimulytics | Grant | Undisclosed | Dublin, Ireland |
| 333 | Hooke Bio | Grant | $2.7M | Limerick, Ireland |
| 334 | Cephalgo | Grant | $2.7M | Strasbourg, France |
| 335 | Molecular Attraction | Grant | Undisclosed | Stockholm, Sweden |
Solar Materials offers photovoltaic modules recycling services.
QuantPi creates automated and scalable solutions for AI model explainability and robustness auditing.
NIMBLE Diagnostics offers a range of paternity, family relationship, and ancestry DNA testing services.
UK-based SME commercialising silk-based peripheral nerve repair conduits
Thirona is a software solutions firm that offers services for software and image analysis services for the health care industry.
X-trodes is a technology start-up that develops unique wearable, wireless technology, and advanced analytics of biopotential signals.
BioSimulytics develops AI-powered software for drug researchers.
Hooke Bio is a biotechnology company providing engineering solutions for the analysis of 3D microtissues for preclinical drug development
Cephalgo offers psychiatrists wearable and discrete electroencephalography equipment that monitors emotions through brainwaves.
Molecular Attraction is a bio-attractant discovery company.
C2C-NewCap has developed a breakthrough supercapacitor contributing towards more sustainable mobility.
EIC Accelerator has invested in 336 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
EIC Accelerator's top investment sectors include Artificial Intelligence (AI), Software, Biotechnology, Machine Learning, Health Care. The firm invests across 18 different industry categories.
Among tracked funding rounds, C2C NewCap received $6.2M in a Grant round. EIC Accelerator's total known invested capital is $1.5B.
EIC Accelerator's average investment size is $5.4M across its portfolio of 336 companies.
Recent EIC Accelerator portfolio additions include Solar Materials, QuantPi, NIMBLE Diagnostics, Newrotex Ltd, Thirona. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors